Get the Stockscreener App
0.00
100.00%
-76.01
Hologic Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$76.01
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$16.97B
Revenue:
$4.13B
Net Income/Loss:
$543.90M
P/E Ratio:
0.00
EPS:
2.41
Net Cash Flow:
$957.20M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$76.07
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
0.00 | 16.97B | 4.13B | 543.90M | 957.20M | 2.41 |
ISRG
Intuitive Surgical Inc
|
458.96 | 160.05B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.43 | 43.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
79.74 | 38.02B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.22 | 37.01B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
230.26 | 33.34B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Argus | Buy → Hold |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-21-25 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
[EFFECT] HOLOGIC INC SEC Filing - Stock Titan
Hologic Stock 2026: Buy or Sell HOLX as Blackstone-TPG Buyout Nears Completion With $76 Cash Offer Plus CVR - International Business Times Australia
Sentiment Review: Is Hologic Inc vulnerable to short sellers2026 Catalysts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Hologic: $18.3 Billion Take-Private Deal Completed As Women’s Health MedTech Company Goes Private - Pulse 2.0
Blackstone and TPG Complete Acquisition of Hologic; Names New CEO - MedTech Intelligence
Hologic (HOLX) executive equity awards cancelled and cashed out in merger - Stock Titan
Hologic (HOLX) president exits stock in $76 cash-and-CVR merger - Stock Titan
Merger leaves Hologic (HOLX) executive without any common shares - Stock Titan
Hologic (HOLX) CFO has equity awards cashed out in Hopper merger - Stock Titan
Hologic (HOLX) COO exits equity as merger pays $76 plus CVR per share - Stock Titan
Hologic (HOLX) counsel’s shares converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) executive equity converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) SVP stock converted at $76 plus CVR in merger - Stock Titan
Merger cashes out Hologic (HOLX) director Amy McBride’s equity awards - Stock Titan
Hologic (HOLX) director exits equity as merger pays $76 cash plus CVR - Stock Titan
Hologic (HOLX) director exits position as merger pays $76 plus CVRs - Stock Titan
Hologic (HOLX) director surrenders options and shares in cash-and-CVR merger - Stock Titan
Hologic (HOLX) director exits stake as Hopper merger pays cash and CVRs - Stock Titan
Hologic (NASDAQ: HOLX) director equity cashed out in merger - Stock Titan
Hologic (HOLX) CEO exits all company stock as $76 per share buyout closes - Stock Titan
Merger cashes out Hologic (HOLX) director Hantson’s stock and options - Stock Titan
Director leaves Hologic (HOLX) after $76 cash plus CVR merger payout - Stock Titan
Hologic (HOLX) officer reports equity cash-out and loss of shares after merger - Stock Titan
ImpediMed Taps Former Hologic Executive for Top Job - Medical Product Outsourcing
Take Profit: Is Hologic Inc attractive for institutional investorsCEO Change & Weekly Stock Performance Updates - baoquankhu1.vn
Hologic goes private: Blackstone, TPG close buyout and name José Almeida CEO - TechStock²
Hologic, Inc.(NasdaqGM: HOLX) dropped from FTSE All-World Index - marketscreener.com
Hologic Goes Private In $18 Billion Blackstone, TPG Acquisition - Sahm
Hologic names José E. Almeida as CEO - Medical Buyer
Hologic, Inc.(NasdaqGS:HOLX) dropped from S&P Healthcare Equipment Select Industry Index - marketscreener.com
Hologic, Inc.(NasdaqGS:HOLX) dropped from S&P 500 Health Care Equipment & Services (Industry Group) - marketscreener.com
Hologic, Inc.(NasdaqGS: HOLX) dropped from S&P Composite 1500 - marketscreener.com
Hologic, Inc.(NasdaqGS: HOLX) dropped from S&P 500 - marketscreener.com
Hologic, Inc.(NasdaqGS: HOLX) dropped from S&P Global BMI Index - marketscreener.com
Hologic, Inc.(NasdaqGS: HOLX) dropped from S&P 500 Equal Weighted - marketscreener.com
Hologic, Inc.(NasdaqGS:HOLX) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index - marketscreener.com
News On Hologic Inc. (HOLX) Now Under HOLX.XX - Moomoo
Hologic, Inc.(NasdaqGS: HOLX) dropped from S&P TMI Index - marketscreener.com
Adia-backed USD 18.3 bn Hologic buyout completed, UAE + Bahrain ink AED 20 bn currency swap, UK’s MHA makes UAE acquisition - EnterpriseAM Egypt
Hologic Taken Private in Blackstone-TPG Acquisition, Leadership Shift - The Globe and Mail
Hologic Goes Private, Hires ex-Baxter CEO Joe Almeida as Chief Exec - Medical Product Outsourcing
Hologic hires former Baxter leader José Almeida as CEO - MedTech Dive
ImpediMed Selects Former Hologic Executive Erik Anderson as Chief Executive Officer - citybiz
Casey’s General Stores Stock Joins S&P 500 As Hologic Acquisition Nears Completion - TIKR.com
Hologic (HOLX) Stock; Trades Flat as CEO Exit and $18.3B Blackstone-TPG Buyout Nears Final Close - MEXC
Blackstone & TPG Complete Hologic Acquisition, Appoint Joe Almeida as CEO - Digital Health News
Hologic (HOLX) Goes Private: Blackstone and TPG Close $17 Billion Acquisition - MEXC Exchange
NORTH STAR ASSET MANAGEMENT INC's Hologic Inc(HOLX) Holding History - GuruFocus
Hologic goes private in $79 per share buyout by Blackstone, TPG - Investing.com Australia
Research Alert: CFRA Drops Coverage On Shares Of Hologic, Inc. - Moomoo
NEXPOINT ASSET MANAGEMENT, L.P.'s Hologic Inc(HOLX) Holding History - GuruFocus
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):